Hyperparathyroidism pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 58: Line 58:


===Pathogenesis of primary hyperparathyroidism===
===Pathogenesis of primary hyperparathyroidism===
*Primary hyperparathyroidism is due to increase in secretion of parathyroid hormone from parathyroid gland.
*Majority of times, increase in secretion of parathyroid hormone is the result of parathyroid adenoma. Other causes of increase in secretion of parathyroid hormone includes parathyroid hyperplasia and parathyroid carcinoma.
*Calcium sensing receptor expression in reduced in parathyroid adenomas resulting in an increase in calcium sensing set point.<ref name="pmid8995751">{{cite journal| author=Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E et al.| title=Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. | journal=Kidney Int | year= 1997 | volume= 51 | issue= 1 | pages= 328-36 | pmid=8995751 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8995751  }} </ref><ref name="pmid8636374">{{cite journal| author=Kifor O, Moore FD, Wang P, Goldstein M, Vassilev P, Kifor I et al.| title=Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. | journal=J Clin Endocrinol Metab | year= 1996 | volume= 81 | issue= 4 | pages= 1598-606 | pmid=8636374 | doi=10.1210/jcem.81.4.8636374 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8636374  }} </ref>
*In parathyroid hyperplasia, an increase in cell number causes increased secretion of parathyroid hormone.
*The exact pathogenesis of [disease name] is not fully understood.
*The exact pathogenesis of [disease name] is not fully understood.
OR
OR

Revision as of 18:24, 16 August 2017

Hyperparathyroidism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyperparathyroidism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyperparathyroidism pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyperparathyroidism pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyperparathyroidism pathophysiology

CDC on Hyperparathyroidism pathophysiology

Hyperparathyroidism pathophysiology in the news

Blogs on Hyperparathyroidism pathophysiology

Directions to Hospitals Treating Hyperparathyroidism

Risk calculators and risk factors for Hyperparathyroidism pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:

Overview

  • The exact pathogenesis of [disease name] is not fully understood.

OR

  • It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
  • [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
  • Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
  • [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
  • The progression to [disease name] usually involves the [molecular pathway].
  • The pathophysiology of [disease/malignancy] depends on the histological subtype.

Pathohysiology

Parathyroid, Vitamin D, and mineral homeostasis

The effect of Parathyroid hormone on mineral metabolism is as follows:[1][2]

  • Effect of parathyroid hormone on inorganic phosphate metabolism:
    • Increases excretion of inorganic phosphate from kidney resulting in decreased serum concentration of phosphate.
  • Effect on parathyroid hormone on calcium metabolism:
    • Direct effect:
      • Increased resorption of bones.
      • Decreases excretion from kidney.
    • Indirect effect:
      • Increases conversion of inactive 25-hydroyxvitamin D to the active 1,25-dihydroyxvitamin D which increases absorption of calcium from gut.Decreased phosphate concentration also increases this conversion process. Vitamin D also synergizes with parathyroid action on bone.
      • Decreased serum inorganic phosphate concentration prevents precipitation of calcium phosphate in bones.
    • Both these direct and indirect mechanism results in an increased serum calcium concentration.
  • Effect of parathyroid hormone on magnesium concentration:
    • Decreases excretion of magnesium resulting in increased serum magnesium concentretion.

Effect of minerals and vitamin D on parathyroid hormone:

  • Decrease in serum calcium concentration stimulates parathyroid hormone.
  • Calcium provides negative feedback on parathyroid hormone.
  • Magnesium provides negative feedback on parathyroid hormone.
  • Vitamin D decreases the concentration of parathyroid hormone.

The sequence of events is shown in the algorithm below:

 
 
 
 
 
 
 
 
 
 
 
Parathyroid hormone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kidney
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Decreased excretion of magnesium
 
 
 
Increasead conversion of inactive 25-hydroyxvitamin D to the active 1,25-dihydroyxvitamin D
 
 
Increase excretion of inorganic phosphate
 
 
 
 
Decrease excretion of calcium
 
 
 
 
 
Increased resorption of bone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increased serum concentration of magnesium
 
 
 
Increased absorption of calcium from gut
 
 
Decreased serum concentration of inorganic phosphate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prevents precipitation of calcium phosphate in bones
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increased serum concentration of calcium
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Calcium-sensing receptors

  • Calcium -ensing receptors are present on parathyroid glands. They are a type of 7-transmembrane receptors in G-protein coupled receptors superfamily of receptors.[3]
  • Calcium-sensing receptors sense change in extracellular concentration of inonised calcium.[4]
  • Calcium-sensing receptor expression in reduced in primary hyperparathyroidism (parathyroid adenomas) and secondary hyperparathyroidism.[5]
  • This reduced expression of receptor causes an increases in calcium sensing set point.[6]
  • This in turn leads to increase in secretion of parathyroid hormone in presence on normal serum concentration of extracellular ionized calcium.

Pathogenesis of primary hyperparathyroidism

  • Primary hyperparathyroidism is due to increase in secretion of parathyroid hormone from parathyroid gland.
  • Majority of times, increase in secretion of parathyroid hormone is the result of parathyroid adenoma. Other causes of increase in secretion of parathyroid hormone includes parathyroid hyperplasia and parathyroid carcinoma.
  • Calcium sensing receptor expression in reduced in parathyroid adenomas resulting in an increase in calcium sensing set point.[5][6]
  • In parathyroid hyperplasia, an increase in cell number causes increased secretion of parathyroid hormone.
  • The exact pathogenesis of [disease name] is not fully understood.

OR

  • It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
  • [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
  • Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
  • [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
  • The progression to [disease name] usually involves the [molecular pathway].
  • The pathophysiology of [disease/malignancy] depends on the histological subtype.

Genetics

  • [Disease name] is transmitted in [mode of genetic transmission] pattern.
  • Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
  • The development of [disease name] is the result of multiple genetic mutations.

Associated Conditions

Gross Pathology

  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Microscopic Pathology

  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

  1. HARRISON MT (1964). "INTERRELATIONSHIPS OF VITAMIN D AND PARATHYROID HORMONE IN CALCIUM HOMEOSTASIS". Postgrad Med J. 40: 497–505. PMC 2482768. PMID 14184232.
  2. Nussey, Stephen (2001). Endocrinology : an integrated approach. Oxford, UK Bethesda, Md: Bios NCBI. ISBN 1-85996-252-1.
  3. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O; et al. (1993). "Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid". Nature. 366 (6455): 575–80. doi:10.1038/366575a0. PMID 8255296.
  4. Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YH, Riccardi D; et al. (1995). "Calcium-ion-sensing cell-surface receptors". N Engl J Med. 333 (4): 234–40. doi:10.1056/NEJM199507273330407. PMID 7791841.
  5. 5.0 5.1 Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E; et al. (1997). "Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism". Kidney Int. 51 (1): 328–36. PMID 8995751.
  6. 6.0 6.1 Kifor O, Moore FD, Wang P, Goldstein M, Vassilev P, Kifor I; et al. (1996). "Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism". J Clin Endocrinol Metab. 81 (4): 1598–606. doi:10.1210/jcem.81.4.8636374. PMID 8636374.

Template:WH Template:WS